3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Other
1
Conditions
Breast Neoplasms
35
Neoplasms
23
Motor Activity
11
Stomach Neoplasms
7
Pain, Postoperative
7
Lung Neoplasms
7
Fatigue
7
Colorectal Neoplasms
7
Pain
5
Anxiety Disorders
5
Polycystic Ovary Syndrome
4
Depression
4
Carcinoma, Hepatocellular
4
Uterine Cervical Neoplasms
3
Thyroid Neoplasms
3
Stomatitis
3
Sleep Initiation and Maintenance Disorders
3
Rectal Neoplasms
3
Prostatic Neoplasms
3
Precursor Cell Lymphoblastic Leukemia-Lymphoma
3
Malnutrition
3
Liver Neoplasms
3
Leukemia, Myeloid, Acute
3
Colonic Neoplasms
3
Agnosia
3
Vomiting
2
Urinary Incontinence
2
Squamous Cell Carcinoma of Head and Neck
2
Parasomnias
2
Ovarian Neoplasms
2
Interventions
Exercise
24
Metformin
19
Tirzepatide
9
Resistance Training
8
Nutrition Assessment
8
Methods
8
Diet Therapy
8
Diet
8
Counseling
7
Surveys and Questionnaires
6
semaglutide
5
Liraglutide
5
Exenatide
5
Early Intervention, Educational
5
Diet, Mediterranean
5
Caloric Restriction
5
Blood Specimen Collection
5
Educational Status
4
Bariatric Surgery
4
Vitamin D
3
Sugars
3
Standard of Care
3
Naltrexone
3
Letrozole
3
Docosahexaenoic Acids
3
Dexamethasone
3
Bupropion
3
exemestane
2
bupropion hydrochloride, naltrexone hydrochoride drug combination
2
Yoga
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
OTHER
×
Obesity
×
Control Groups
×
Clear all
NCT01150539
2021-08-25
POLY
Pennington Biomedical Research Center
Phase NA
Completed
8 enrolled